214 related articles for article (PubMed ID: 34283652)
1.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
2. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
4. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
5. BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract][Full Text] [Related]
6. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
7. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
Liu J; Jiang X; Zou A; Mai Z; Huang Z; Sun L; Zhao J
Cancer Res; 2021 Jan; 81(2):344-355. PubMed ID: 33203701
[TBL] [Abstract][Full Text] [Related]
8. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
9. Function of miR‑152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c‑MET.
Li M; Li Z; Wang X; Wang Y; Zhao C; Wang L
Oncol Rep; 2018 Mar; 39(3):1173-1180. PubMed ID: 29286169
[TBL] [Abstract][Full Text] [Related]
10. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
11. MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway.
Jia B; Zhang S; Wu S; Zhu Q; Li W
IUBMB Life; 2021 Jan; 73(1):264-272. PubMed ID: 33326690
[TBL] [Abstract][Full Text] [Related]
12. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.
Rodini CO; Xavier FC; Paiva KB; De Souza Setúbal Destro MF; Moyses RA; Michaluarte P; Carvalho MB; Fukuyama EE; ; Tajara EH; Okamoto OK; Nunes FD
Int J Oncol; 2012 Apr; 40(4):1180-8. PubMed ID: 22227861
[TBL] [Abstract][Full Text] [Related]
13. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
15. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5.
Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L
Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
Liu Z; Li H; Fan S; Lin H; Lian W
Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
[TBL] [Abstract][Full Text] [Related]
19. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.
Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW
Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]